Location History:
- Del Mar, CA (US) (2002)
- San Diego, CA (US) (2007 - 2024)
Company Filing History:
16 out of 2,078 
2 out of 363 
1 out of 32 
Years Active: 2002-2024
Title: Innovator Profile: Anne Fourie, Pioneer in Autoimmune Disease Treatment
Introduction: Anne Fourie is a prominent inventor based in San Diego, California, with an impressive portfolio of 19 patents. Her groundbreaking work focuses on the development of therapeutic compositions aimed at treating autoimmune conditions and related disorders.
Latest Patents: Among her notable contributions, Anne's latest patents include "Compositions of Peptide Inhibitors of Interleukin-23 Receptor," which pertains to novel compositions that target the IL-23R and are designed to provide effective treatments for autoimmune inflammation. Another significant patent is centered around "Anti-HLA-C Antibodies and Uses Thereof," which details new anti-HLA-C6 antibodies, their encoding nucleic acids, and their potential applications in the treatment of autoimmune diseases.
Career Highlights: Anne Fourie's has made significant strides in the pharmaceutical industry through her roles at leading companies such as Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. Her work has been pivotal in advancing medical therapies, particularly in addressing complex autoimmune conditions.
Collaborations: Throughout her career, Anne has collaborated closely with notable colleagues, including Xiaohua Xue and David A. Kummer. These partnerships have proven fruitful in furthering research and innovation within her field.
Conclusion: Anne Fourie's contributions to the field of biotechnology and pharmaceuticals demonstrate her commitment to improving health outcomes for patients suffering from autoimmune diseases. Her extensive patent portfolio and collaborative efforts underscore her status as a leading innovator in medical research.